Interactive Session:
167. Hepatitis C in Practice
Saturday, October 22, 2011: 1:45 PM-3:15 PM
Room: Grand Ballroom (East-West)

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • use laboratory testing to manage HCV treatment decisions
  • recognize the adverse effects of HCV treatment
  • describe how drug interactions affect the treatment of HCV in HIV-infected persons

Target Audience: Pharmacists, HIV Clinicians, Fellows-in-Training, Clinicians, Academicians

Tracks: HIV

Interactive Moderators:  Eliot Godofsky, MD, Univ. Hepatitis Ctr. and David Thomas, MD, MPH, Johns Hopkins University

Presentations:

1:45 PM
Interactive Panelist
Mark Sulkowski, MD

2:05 PM
Interactive Panelist
Barbara H. McGovern, MD

2:25 PM
Interactive Panelist
Adeel A. Butt, MD, MS, FIDSA

2:45 PM
Interactive Panelist
Douglas Dieterich, MD

CME Credits: Maximum of 1.5 hours of Category 1 credit possible

ACPE Credits: ACPE 1.5 knowledge-based contact hours (0.15 CEU) of Pharmacy CE

ACPE Number: 0461-9999-11-140-L01-P

Disclosures:

E. Godofsky, Roche: Investigator, Research support and Speaker honorarium
Merck: Investigator, Research support
Gilead: Investigator, Research support
Vertex: Investigator, Research support
Human Genome Sciences: Investigator, Research support
Idenix: Investigator, Research support
Novartis: Investigator, Research support

D. Thomas, merck: Consultant and Grant Investigator, Consulting fee and Grant recipient
Gilead: Grant Investigator, Grant recipient

M. Sulkowski, Merck: Investigator and Scientific Advisor, Consulting fee and Research support
Vertex: Investigator and Scientific Advisor, Consulting fee and Research support
Abbott: Investigator and Scientific Advisor, Consulting fee and Research support
BMS: Investigator and Scientific Advisor, Consulting fee and Research support
BIPI: Investigator and Scientific Advisor, Consulting fee and Research support
Tibotec: Investigator and Scientific Advisor, Consulting fee and Research support
Pharmasset: Investigator and Scientific Advisor, Consulting fee and Research grant
Novartis : Investigator and Scientific Advisor, Consulting fee and Research support
Roche/Genentech: Investigator and Scientific Advisor, Consulting fee and Research grant

B. H. McGovern, None

A. A. Butt, None

D. Dieterich, Achillion : Consultant and Scientific Advisor, Consulting fee
Boehringer Ingelheim: Consultant and Scientific Advisor, Consulting fee and Research support
Genentech : Consultant and Scientific Advisor, Consulting fee
Gilead : Consultant and Scientific Advisor, Consulting fee
Idenix: Consultant and Scientific Advisor, Consulting fee
Roche : Consultant and Scientific Advisor, Consulting fee
Merck: Consultant and Scientific Advisor, Consulting fee

See more of: Interactive Session

Findings in the abstracts are embargoed until 12:01 a.m. EST Thursday, Oct. 20 with the exception of research findings presented at IDSA press conferences.